Myriam Weber
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C, Vernazza P, Bühler P, Schüpbach R, Gómez-Mejia A, Popa A, Bergthaler A, Penninger J, Flatz L. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:1746.
Nov 2, 2021Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Nov 2, 2021Clin Infect Dis 2021; 73:1746
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner, Kohler Philipp, Kahlert Christian, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Hasan Ali O, Penninger J, Bergthaler A, Popa A, Gómez-Mejia A, Schüpbach R, Bühler P, Vernazza P, Kahlert C, Kohler P, Albrich W, Kern L, Thiel S, Weber M, Paprotny M, Brugger S, Risch L, Bomze D, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
Jan 2, 2021Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Jan 2, 2021Clin Infect Dis 2021; 73:e2869-e2874
Hasan Ali Omar, Penninger Josef M, Bergthaler Andreas, Popa Alexandra M, Gómez-Mejia Alejandro, Schüpbach Reto A, Bühler Philipp K, Vernazza Pietro, Kahlert Christian, Kohler Philipp, Albrich Werner, Kern Lukas, Thiel Sarah, Weber Myriam, Paprotny Matthias, Brugger Silvio D, Risch Lorenz, Bomze David, Flatz Lukas
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Risch M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Renz H, Kohler P, Vernazza P, Kahlert C, Paprotny M, Bodmer T, Egli K, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Risch L. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Biomed Res Int 2020; 2020:9878453.
Nov 16, 2020Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Nov 16, 2020Biomed Res Int 2020; 2020:9878453
Risch Martin, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Renz Harald, Kohler Philipp, Vernazza Pietro, Kahlert Christian, Paprotny Matthias, Bodmer Thomas, Egli Konrad, Weber Myriam, Thiel Sarah, Grossmann Kirsten, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Risch Lorenz
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
Baron R, Bodmer T, Imperiali M, Heer S, Renz H, Flatz L, Kohler P, Vernazza P, Kahlert C, Paprotny M, Ferrara F, Egli K, Risch L, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Bigler S, Risch M. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study. Clin Chem Lab Med 2020; 58:2131-2140.
Aug 31, 2020Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
Aug 31, 2020Clin Chem Lab Med 2020; 58:2131-2140
Baron Rita Christiane, Bodmer Thomas, Imperiali Mauro, Heer Sonja, Renz Harald, Flatz Lukas, Kohler Philipp, Vernazza Pietro, Kahlert Christian, Paprotny Matthias, Ferrara Francesca, Egli Konrad, Risch Lorenz, Weber Myriam, Thiel Sarah, Grossmann Kirsten, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Bigler Susanna, Risch Martin
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
Kovac M, Egli K, Imperiali M, Heer S, Salimi Y, Renz H, Kohler P, Vernazza P, Kahlert C, Paprotny M, Bodmer T, Ferrara F, Risch L, Thiel S, Weber M, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Bigler S, Risch M. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA). Diagnostics (Basel) 2020; 10
Aug 14, 2020EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
Aug 14, 2020Diagnostics (Basel) 2020; 10
Kovac Marc, Egli Konrad, Imperiali Mauro, Heer Sonja, Salimi Yacir, Renz Harald, Kohler Philipp, Vernazza Pietro, Kahlert Christian, Paprotny Matthias, Bodmer Thomas, Ferrara Francesca, Risch Lorenz, Thiel Sarah, Weber Myriam, Grossmann Kirsten, Wohlwend Nadja, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Bigler Susanna, Risch Martin